Last reviewed · How we verify
High blood pressure treatment
At a glance
| Generic name | High blood pressure treatment |
|---|---|
| Sponsor | University of Rochester |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Unrelated AE
Key clinical trials
- The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis (NA)
- Development and Validation of a KAP Questionnaire for Secondary Hypertension: Evaluating a Community Short-Video Intervention in Rural Beijing (NA)
- Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant (PHASE3)
- A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) (PHASE3)
- Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE) (NA)
- Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure (NA)
- A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) (PHASE2)
- DASH INtervention to INvestigate the Gut (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High blood pressure treatment CI brief — competitive landscape report
- High blood pressure treatment updates RSS · CI watch RSS
- University of Rochester portfolio CI